Compare InventionMed SA with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 0%
- Poor long term growth as Net Sales has grown by an annual rate of 36.45% and Operating profit at 22.97% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -1.42
2
With a growth in Operating Profit of 419.45%, the company declared Outstanding results in Jan 70
3
With ROE of 4.15%, it has a expensive valuation with a 0.00 Price to Book Value
4
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-41.26%
0%
-41.26%
6 Months
-37.13%
0%
-37.13%
1 Year
-53.36%
0%
-53.36%
2 Years
-37.32%
0%
-37.32%
3 Years
-28.48%
0%
-28.48%
4 Years
-29.55%
0%
-29.55%
5 Years
-66.39%
0%
-66.39%
InventionMed SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
36.45%
EBIT Growth (5y)
22.97%
EBIT to Interest (avg)
-1.42
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.34
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
3.33
EV to EBITDA
1.94
EV to Capital Employed
0.77
EV to Sales
0.89
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
18.85%
ROE (Latest)
4.15%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
0.80
1.00
-20.00%
Operating Profit (PBDIT) excl Other Income
0.60
0.80
-25.00%
Interest
0.30
0.80
-62.50%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.20
-0.10
300.00%
Operating Profit Margin (Excl OI)
479.60%
527.30%
-4.77%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -20.00% vs 150.00% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 300.00% vs -200.00% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
3.20
0.30
966.67%
Operating Profit (PBDIT) excl Other Income
1.00
-2.10
147.62%
Interest
1.60
1.50
6.67%
Exceptional Items
0.00
-0.40
100.00%
Consolidate Net Profit
-0.70
-4.40
84.09%
Operating Profit Margin (Excl OI)
37.90%
-10,687.30%
1,072.52%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 966.67% vs 0.00% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 84.09% vs -131.58% in Dec 2024
About InventionMed SA 
InventionMed SA
Software Products
Inventionmed SA, formerly known as Athos Venture Capital SA, is a Poland-based medical technology company. The Company is focused on developing TutorDerm, an advanced medical simulator based on virtual reality (VR) technology for the purpose of training doctors, medical students and cosmetologists in conducting dermatological procedures.
Company Coordinates 
Company Details
Bydgoskich Przemyslowcow 6/116 , BYDGOSZCZ None : 85-862
Registrar Details






